These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10090401)

  • 1. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics.
    Eid P; Meritet JF; Maury C; Lasfar A; Weill D; Tovey MG
    J Interferon Cytokine Res; 1999 Feb; 19(2):157-69. PubMed ID: 10090401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oromucosal administration of IFN-alpha on allergic sensitization and the hypersensitive inflammatory response in animals sensitized to ragweed pollen.
    Meritet JF; Maury C; Tovey MG
    J Interferon Cytokine Res; 2001 Aug; 21(8):583-93. PubMed ID: 11559436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oromucosal interferon therapy: marked antiviral and antitumor activity.
    Tovey MG; Maury C
    J Interferon Cytokine Res; 1999 Feb; 19(2):145-55. PubMed ID: 10090400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oromucosal interferon therapy: relationship between antiviral activity and viral load.
    Schellekens H; Geelen G; Meritet JF; Maury C; Tovey MG
    J Interferon Cytokine Res; 2001 Aug; 21(8):575-81. PubMed ID: 11559435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo 2',5'-oligoadenylate synthetase activity induced by recombinant DNA-derived bovine interferon alpha I1 in bovine alveolar macrophages and blood mononuclear cells.
    Holland SP; Fulton RW; Short EC; Wyckoff JH; Fox JC
    Am J Vet Res; 1991 Nov; 52(11):1779-83. PubMed ID: 1664669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
    Sugawara T
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell and type specificity of interferon action. Unusual characteristics of the transcriptional control of gene expression by interferon-gamma in T cells.
    Gribaudo G; Gariglio M; Cavallo G; Landolfo S
    Eur J Immunol; 1990 Jun; 20(6):1243-9. PubMed ID: 2114996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
    Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
    Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.
    Landolfo S; Gariglio M; Gribaudo G; Jemma C; Giovarelli M; Cavallo G
    Eur J Immunol; 1988 Apr; 18(4):503-9. PubMed ID: 2835246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of blood 2',5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau.
    Nakajima A; Sokawa Y
    J Interferon Cytokine Res; 2002 Mar; 22(3):397-402. PubMed ID: 12034048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
    Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
    J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
    Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
    Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oromucosal cytokine therapy: mechanism(s) of action.
    Tovey MG
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):125-31. PubMed ID: 12499797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple mixing of IFN with a polysaccharide having high liver affinity enables IFN to target to the liver.
    Tabata Y; Matsui Y; Uno K; Sokawa Y; Ikada Y
    J Interferon Cytokine Res; 1999 Mar; 19(3):287-92. PubMed ID: 10213468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of interferon-inducible genes in cells of chronic myeloid leukemia patients responsive or resistant to an interferon-alpha treatment.
    Clauss IM; Vandenplas B; Wathelet MG; Dorval C; Delforge A; Content J; Stryckmans P; Huez GA
    Blood; 1990 Dec; 76(11):2337-42. PubMed ID: 1701667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.